Antoine Regnault

Does the MDS-UPDRS provide the precision to assess progression in early Parkinson’s disease? Learnings from the Parkinson’s progression marker initiative cohort

Babak Boroojerdi, Thomas Morel, B. Boroojerdi, 2019, Journal of Neurology.

Guidelines for Inclusion of Patient-Reported Outcomes in Clinical Trial Protocols: The SPIRIT-PRO Extension

Joanna Coast, Heather Draper, Andrew Bottomley, 2018, JAMA.

Identification of noncompliant glaucoma patients using Bayesian networks and the Eye-Drop Satisfaction Questionnaire

Philippe Denis, Jean-Paul Renard, J. Nordmann, 2010, Clinical ophthalmology.

Sample size used to validate a scale: a review of publications on newly-developed patient reported outcomes measures

Véronique Sébille, Jean-Benoit Hardouin, E. Anthoine, 2014, Health and Quality of Life Outcomes.